Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayer, S. A.
Right arrow Articles by Pulsinelli, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayer, S. A.
Right arrow Articles by Pulsinelli, W. A.

Stroke, Vol 23, 242-246, Copyright © 1992 by American Heart Association


ARTICLES

Failure of GM1 ganglioside to influence outcome in experimental focal ischemia

SA Mayer and WA Pulsinelli
Department of Neurology, Cornell University Medical College, New York, N.Y.

BACKGROUND AND PURPOSE: Reports of improved short-term (less than 72 hours) outcome in experimental models of mechanical and ischemic central nervous system injury suggest that exogenous ganglioside administration may confer a protective effect on neural tissue. We studied the effect of the monosialoganglioside GM1 on cerebral infarction and edema in spontaneously hypertensive rats subjected to permanent focal cerebral ischemia. METHODS: GM1 or normal saline was injected intramuscularly once a day for 3 days before and 30 and 120 minutes after occlusion of the right middle and common carotid arteries. Following a 24-hour survival period, the volume of infarction was measured by computer-assisted image analysis, and the extent of edema was assessed by measurements of tissue water content and hemispheric volume. RESULTS: Infarct volume was similar among the GM1- treated (n = 10) and saline-treated (n = 10) rats (212 +/- 10 versus 220 +/- 13 microliters, respectively). In a second series of experiments, the brain water content and edema volume of the ischemic right hemisphere in GM1-treated rats (n = 10) did not differ from saline-treated controls (n = 10). CONCLUSIONS: GM1 ganglioside does not effectively reduce cerebral infarction caused by permanent focal ischemia.


This article has been cited by other articles:


Home page
StrokeHome page
A. Slivka, E. Murphy, and L. Horrocks
Cerebral Edema After Temporary and Permanent Middle Cerebral Artery Occlusion in the Rat
Stroke, June 1, 1995; 26(6): 1061 - 1066.
[Abstract] [Full Text]